RE:RE:RE:RE:New Press Release - Oncolytics Biotech® and SOLTI Present Positive Translational Data at SABCSNO NO NO Canaduh.
Reread the new release "We believe that analysis of TIL clone expansion could become a helpful precision tool to provide an early indication of treatment response and serve as a potential guide to patient care with pelareorep. "
We "believe" is NOT proof. ONCY never states IS, for years all we have is "could", "might", "suggests"... stop the pumping hopium please..
IF ONCY had a confirmed biomarker, that had statistically demonstrated (to the acceptance of the FDA) a direct relationship to better outcomes, then ONCY would be talking accelerated approval.
And the reason the PanCan study was going to take several years, and why Matt stated that a Phase III in mBC would be a traditional Phase III, is ecactly beause they have not proven their biomarker translates into improved outcomes... for now that is only anecdotal.,,
Thsi was yet another nothing burger of a press release... Do bear in mind that you have been consistently wrong for the 3 years I've been reading your posts... always hopium...
The market wants one thing... real, unassaisable data that shows Pela works, and a partner to get them across the line, because they absolutely cannot afford to run even 1 phase III alone... why does every trial partner fall shy of taking an equity stake.. answers ????
wishful pumping is wealth destroying for the unititiated...